SUBSCRIBE
SUBSCRIBE
News   Business

EpiCept Corporation’s Board of Directors Appoints New Independent Member

April 28, 2011 | 
1 min read
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today the appointment of Keith L. Brownlie, former partner of Ernst & Young LLP, to its Board of Directors.
People
MORE ON THIS TOPIC
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Kardigan cozies up to public markets to support heart disease drugs
May 27, 2026
 · 
14 min read
 · 
Editorial Team
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
J&J trims New Jersey headcount by 56
May 27, 2026
 · 
56 min read
 · 
BioSpace Editorial Staff
Isometric Office chair with vacancy sign isolated on blue background. Employment, vacancy and hiring job vector concept
Regulatory
Makary’s reforms will live on at FDA even as leadership turns over
May 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds
May 27, 2026
 · 
2 min read
 · 
Jef Akst